Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

AstraZeneca has unveiled positive trial results for a breast cancer drug that can stop mutating tumours before they start to grow, hoping it will be one of a portfolio of medicines that will propel it ...

Asad Haider, head of the healthcare business unit within Goldman Sachs Research, now forecasts the market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, to ...

AstraZeneca Plc’s experimental breast cancer pill delayed disease progression by over six months, according to data from a ...

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

AstraZeneca India Pharma receives government approval for import and distribution of lung cancer medication Osimertinib ...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence ...

AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

AstraZeneca Pharma India Limited reported a strong financial performance for the fourth quarter ended March 31, 2025. The ...

AstraZeneca Pharma India posts 48% rise in Q4FY25 net profit to Rs 58.25 crore, driven by strong growth in oncology and ...